Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/3278292

Beta release

Statistics of DNL104, a centrally penetrant RIPK1 inhibitor, inhibits RIP1 kinase phosphorylation in a randomized phase I ascending dose study in healthy volunteers
Statistics for this year
PeriodVisitsDownloads
2024172150
Statistics for the last 3 months
PeriodVisitsDownloads
2024-092622
2024-101917
2024-111010